RHOA and breast carcinoma: The CD99 molecule has previously been linked to Rho GTPase activity, actin dynamics and growth factor signalling in breast cancer; EGFR stimulates RhoA and Rac1 activity and actin reorganization, and these pathways are antagonised by CD99-mediated signalling (Lee et al., 2020).